OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← The Ch Foundation (UK)

2024-03-31-accounts

Charlly Re8151ratlon No.. IIS6222 Company Reglslratlon No.. 08702259 (England and Wale5) The CH Foundation (UK) (a Charitable Company Llmited by Guaranteel Trustees, Report and Financial Statements For the Period Ended 31 March 2024

The CH Foundation (UK) IA Company Limited by Guarantee) Charity Registration No: 1156222 Company Re8iStration No: 08702259 Contents Pa8e Legal and Administrative Information Trustees, Report Statement of TfU5tees' Re5pon51bllllles Independent Auditors, Report io ststement of Financial Actlvltles 13 Bèlènce Sheet 14 Statement of Cash Flows 15 Notes to the Flnancial Statements 16

The CH Foundation IUKI IA Company Limited by Guarantee) Charity Re8i5tration No.. 1156222 Company Registratlon No: 08702259 Legal and Admln5stratlve Informatlon Dlrertors and Trustees Sir Chrlstopher Hohn Mr Matthew Kin8 Charlty Number 1156222 CDmpany Number 08702259 Re8l$tered Offlce 7 Cllfford street London WIS 2FT 8•nk•r HS8C 8ank PIC 8 Canada Square London E14 5HQ Independent Audliors Pricewaterhousecoopers One Spencer Dock North Wall Quay Dublin I Ireland

The CH Foundation IUKI IA Company Limited by Guarantee) Charity Registration No.. 1156222 Company Registration No: 08702259 Trustees. Report The Trustees present their report together wlth the audited financial statements of The CH Foundatlon IUKI Ithe "Foundation") for the period ended 31 March 2024. During the perlod, the Foundation ehanged Its accountin8 refèrencÈ date from 28 February129 February in a leap yearl to 31 March. The financial statements are for the 13 month period to 31 March 2024, whi15t the comparatives afe for the 12 month period to 28 February 2023. Unless Otherwise noted, references to "Period Ended 31 March 2024" in the financial staternents, Includlng the headers, are for the 13 month period from l March 2023 to 31 March 2024. The financial statements have been prepared in accordance wlth the accountin8 policies set out on pa8e$ 16 to 18 and comply wlth the current Statutory requirements, the Charities Aet 2011. the Companies Act 2006. the Memorandum and Artlcles of Association, and Accountlng and Rèportin8 by Charities- Statement of Recommended Practlce applicable to charities preparing their accounts in accordance with the Flnancial Reportln8 Standard applicable in the UK and Republic of Ireland IFRS 102) leffective l January 20191. Status The Foundatlon was incorporated on 23 September 2013 as a charitable company Ilmited by guarantee and rezlstered as charlty on 17 March 2014, for excluslvely charitablè purposes pursuant to ils Articles of A550clatlon dated 23 September 2013. The Articles of Assoclation defines the objects and powers of the Foundation. F¢wndatbon ObJ¢¢tlves and Ml$slon The Foundatlon's oblectlves, as stated in the Artlcles of Asssxiation, are the holdin8 of Incorne and property upon trust and to apply the income for the public benefit foi exclusively charitable objects •nd purposes In any part of the world. In settln8 the Foundatlon's objectlves and plannin8 its actlvlties. the Trustees (who are also directors) have con51dered Section 17 of the Charitles Act 2011. In doing so they are satisfied that they have complied wlth thelr duty to have iegard to the Public Benefit 8uidance published by the Charlty CommSssion, The Foundation's activities and achlevements are outlined throu8hout this Trustees, Report and the Trustees belleve they fully demonstrate that the Foundation is providlng publlc benefit. The main objectives of the Foundatlon, as a8reed by the Trustees. are to., i) provlde asslstance to those who are in need by reason of povertV sickness or human suffering as a result of human traffickin8 or other serious or orBanlsed crlmlnal behavlour,. advance educatlon and to promote health,. and promote such other purposes belng exclusively charitable a5 agreed by the Trustees. 21 31 Or8anlsatlon The Board of Trustees meets to review and updatè the Foundatlon's strategy and areas of artivity Includlng conslderation of 8rant.makin& a review of the reserves policy as well as the overall rlsk proflle of the Foundatlon. Fundra151n8 The Foundation does not seek to raise funds from the public and has not en8a8ed wlth any professional fund-raiser or eommerclal partlclpator to raise funds. Appolntment olTrustees The Trustees who held office during the period were,. Slr Chrlstopher Hohn Mr Matthew King The Trustees are selected on the basis of their skills and expertlse and the contribution, in particular Sn the areas of busine mana8ement and development, which they can make to determine the strategy ènd policies of the Foundation. The Trustees are responsible for finance, development and planning. There Is no formal pro¢e5s for trainlng Trustees, but training is provided to individual Trustees and to the Trustees as a whole as needs arise.

The CH Foundation IUKI IA Company Limited by Guarantee) Chafity Re81Stration No: 1156222 Company Registration No: 08702259 Trustees, Report (continued) Appdntment of Twstees fcontlnuedj All Trustèès 8iVè thèir time freély and no Trustee remunèration was paid in the period. Reserves Pollcv The Trusteès arè committed to applyin8 the Foundation's resources in a respons*Jle manner for the purposes of yieldlng maximum benefit. The Trustees are aware resetyes are needed to bridBe the gap between the spending and receiving of income. The Trustees aim to maintain free reserves in unrestricled fund5 Ot a level that will provide sufficient funds to respond to appllcations lor grants and ensure that support and governance costs are covered. Restricted Fund5 Restricted Funds are 8enerated when the donor stipulates how their donatlon may be spent. In most cases, there will be a time lag between when such funds are receNeLI and when they are expensed. The Trustees ensure that these funds are expensed in accordance with the terms under which they have been donated to the Foundatlon. Durln8 the period no amounts were donated whlch had festrbrtlons placed on them (year ended 28 February 2023., £nill, Expendoble Endowment Expendable Endowment Funds include all funds re¢elved whi¢h the Trustees are authorlsed to spend when and11 they declde to spend these funds. The funds mav be used to further the speclflc charltable purposes the Foundatlon was established to support. These costs can include both dirert an(J support costs assoclated wlth acllvltles undertaken by the Restricted Funds withln the Foundation. Operotlonal ReseThes Cash flow projections for income and expenditure aré regularly reviewed by the Trusteès to ensure that the level of dSsposable net assets Is adequate and that the Foundatlon Is In a posltlon to meet all Its 8rant-makin8 ènd working capital cornmltments for the foreseeable future. In the event that the Trustees find themsefves unable to meet the Foundatlon's commitments from reserves of Unrestritted Funds at their disposal, they will, draw on the Expendable Endowment to meet those commitment5 a5 nece55ary. The reservès poli¢y is reviewed annually to rea5se55 the risks and reflect any changes to the Foundatbon's Income, capital, financial obligations and long term plans for charltable expenditure. The Unrestricted Fund5 are expendable at the discretlon of the Board of Trustees In furtherance of the objects of the Foundatlon. Investment Pollcv Under the Artlcles of Assoclatlon, thè Foundation has the power to invest in any way the Trustees wish. The Trustees, havSnB regard to the Ilquidty requSremènts of the Foundation and to the reserves policy currently operate policy of keepin8 availablè funds in an interest bearin8 deposit account. Grantln8 Pollcy The Trustees meet regularly to consider what 8rantS they wlll make and to review any feedback they have received. The Trustees are committed to applying the Foundatlon's resources in a responsible manner for the purposes of yieldin8 maximum benefit. Rlsk Statement The Trustee5 are responsible for the management of the risks faced bv the Foundation and have examined the major strategi¢, business and operational risks to which the Foundatlon Is and may be exposed. They are satlsfled that the systems and controls are in place to mitigate and m?na8e exposure to such malor rlsks identlfied by the Trustees. They continue to review current proce5se5 recognlsinB that systems can only provide reasonable but not absolute assurance that major rlsks have been adequately managed.

The CH Foundation IUKI IA Company limited by Guarantee) Charity Registration No: 1156222 Company ReBlstratlon No: 08702259 Tru5tees' Report (continued) Rl$k Statement (contlnuedj The Foundatlon's principal risks tan be broodly grouped as follows: Strotegic rlsk Stratègic risks are those that arise from the declslons taken concernin8 the Foundation's objectlves and ability to meet those objettive5. The Foundation has a clear vision, mission and strategic plan that have been agreed by the Trustees. The Trustees regularly revlew the pro8ress of the Foundation in relation to Its vlslon, misslon, strate8i¢ objectives and annual targets. Operotlonol rlsk Operational risk is the risk of1055 resultlng from Inadequate or failed internal processes and systems, or from external events. The Foundation has approprlate policies and controls in place to manage its operatlonal risk. includin8 System failures. fraud and theft, and fallure to comply with le8al. regulatory and statutory requlrements. Morketrlsk The Foundation's exposure to market rlsk Is Ilmlted to currenry exehan8e risk and price risk. The currency exchan8e risk arises from the investments held In currencies othèr than the funrtional currency of the Foundatlon. The Foundatlon doe5 not actively seek to hed8e its exposure to foreign exchange rlsk. The price risk arises on the investments due to thehr exposure to fluctuations in market prices (other than currency exchange risk), whether those changes are caused by factors specific to the financial instrument or Its Issuers. or factors affècting all Similar financlal Instruments traded in the market. Credlt r15k The Foundation's exposure to credit risk arises malnly through its cash and cash equivalents. The Foundatlon holds all cash with banks whom the Foundatlon has strong, well.established relation5hip5 and who typlcally have a minlmum Moody's or S&P fatin8 of investment grade. At the reportinB date, the maximurn exposure to credlt rlsk Is represented by the carryln8 amount in the Balance Sheet. Llquldlty rlsk Llquidity risk is the risk that the Foundation wlll encounter dlfflcultles In meetlng the obllgatlons assoclated with its financial liabilities that are settled by deliverin8 cash or another financial asset. The Foundation expects to meet Its flnanclal obllgatlons through operatin8 cash nows. In the event that the operatin8 cash flows would not cover all the flnanclal obli8ations thè Foundation h?5 cash reserves and credlt facllltles available. Flnanclal Revlew The Trustees are satisfied wlth the results for the period and are of the vlew that the outlook of the Foundation remalns PQSltive, The Foundatlon's incomln8 resources and charltable giant expendlture increased during the perlod, All voluntary donations come from a select number of donors. each donor a related party of the Foundatlon. The Trustèes arè anticlpatin8 a continued ￿creaSe h incomin8 donations and outgolng grants in future years. Totsl Incomin8 resources, made up of voluntary donations, gift aid, interest recelved and Investment income, amounted to £152,339,641 {year ended 28 February 2023.. £78.515,2891. Durin8 the period, the Foundation continued to fulfil its main objects by grantlng £139,561.979 (year ended 28 February 2023.. £69,701,230). The a55et base of the Foundation at 31 March 2024 amounted to £40,348.512 {year ended 28 February 2023.. £24,455.0441 and is predominately made up of investments and cash at bank. Thè asset base will enable the Foundation io rneet its on8oin8 object5. Achlevefflents and Perfom7ance During the period, the Foundat*on entered into a real estate purchase agreement to acquire a property in the USA for a purchase prlce. inclusive of transaction costs and taxes, of $44,069,437 IE34,689,¢X)81, The Foundation also entered into a donation agreement with MANA Nutrltive Aid Produtts Incorporated I"MANA"I, a charltable organisation reeistered in the USA, to grant the rlghts, tltle and interèst in the property to MANA. The property was donated to MANA during the period and h45 provlded MANA with an additional industrial warehouse and manufacturin8 faality to manufacture ready-to-use therapeutic food l RUTF I.

The CH Foundation IUKI IA Company Limited by Guaranteel Charity Re8lStration No.. IIS6222 Company Registration No- 08702259 Trustees, Report {continuedJ Athlevements and Performance (continued) In addltion to the donation of the property. the Foundation granted cash of s85.0￿,(￿N){£6?.372,2G4j to MANA. The total amount 8ranted to MANA during the period was $129,069,4371£102.061.2731 (year ended 28 February 2023.. $36.500,000 1£29,158,08111. MANA'S rnigsion is to end malnutrition and h35 developed and produced RUTF In the form of peanut butter paste. The purpose of the 8rants is to support MANA in expanding its production capacitv. During the period. the Foundation granted $5,760.0￿ 1£4,716,1701 (year ended 28 February 2023: $14,590,OCiI 1£11,593,27111 to the Kailash Satyarthl Chlldren's Foundation I'KSCF"). a charitable organi5ation registered in Indla. KSCF has. through Con￿rted and sustained actions, demonstrated that the need for a child frlendly sotiety can be achieved through dirKt and contlnued grassroots level interactlon. KSCF continues to fight agalnst all kinds of child rights violation, including chlld labour. child trafficking and chlld sèxual abuse. The purpose of the 8rants is to further KSCF'S campaign against trafficking and chlld sexual abuse. Ourln8 the period, the Foundatlon granted $2.000.0001£1,596,3861 (year ended 28 February 2023: $1,000,OIXI1£756,0061I to rnyAgro. a charltable organisation re8istered in the USA. myAgro has pioneered the use of mobile layaway and quickly evolved into providin8 comprehensive 5UPPOrt to smallholder farmers on every level. The purpose of the 8rant is to allow myAgro to get this solution into the hands of more farmers in West Africa and demonstrate the effectivenes5 of a savln85.led approach that enables farmers to lift themselves out of the cycle of poverty, Durlng the period, the Foundatlon granted $1,Q)O,0001£804,3891 lyear ended 28 February 2023: $l.000,OL￿1756,0O6)l to Noora Health, a charltable or83nisation registered In the USA. Noora Health's mission is to 8ive proper reco8nitlon and support to famlly care8ivers to improve health outcomes, reduce preventable complications, avold readmissions and mortallty. Across India and Ban8ladesh, Noora Health work In close collaboration with public health systems and local partners to Implement the Care Companion Program I"CCP"l. The purpose of the grant Is to allow Noora Plealth to continue to scale their reach to 70 million family careglvers and roll.out CCP to more facllitles and condition areas. Durin8 the period, the Foundatlon 8ranted $150,CQO 1£117,2711 (year ended 28 February 2023,. SICQ,000 1£81,65511 to Hanover Charities l Hanover l. a charitable or8anisation in Jamaica, for Hanover's scholarship programme. Education is a kev focus for Hanover and there are several education-based schemes supported by the charlty, Includin8 scholarshlps that have been awarded In the fields of medicine, law, educatlon, soclal work, nursing, communications and a8rlculture, Durin8 the period, the Foundation 8ranted $25,0(M),I￿0 1£20,515.6821 to UNICEF, an Internatlonal Intef.governmental charitable organlsatlon whose 8lobal headquarters are in the USA. The grant was a contribution to UNICEF'S Nutrition Match Fund. The Nutrition Match Fund focuses on combatting child wastlng, through the procurement and distribution of ready-to. use therapeutic food, UNICEF estimate that 70% of the global estimated number of chlldren suffering from severe wastln8 do not have access to treatment, Durin8 the perbod, the Foundation 8ranted $10,000,OCQ1£8,448,2291 to Acumen, a charitable organisation re8iStered in the USA. Acumen has a successful track record in sourcing and executlnB equity investment opportunities in the clean energy. agriculture and health<are sectors. which provlde enwlronmental and livelihood impacts. The grant was a contribution to "The Hardest-to-Reach" pro8ramme which aims to provide clean energy for an estimated 60 mllllon people. Durin8 the perlod, the Foundation granted $1,000,0001£817.7821 to Splash International I'Spla5h"l. a charitable or8an15atlon re8iStered In the United States. Splash works to provide clean water. sanitstion, and hy8iene 501utbons to children living in urban povèrty in Asia and Afrlca. During the period. the Fovndalion granted $200.CK)01£160.4611 to The Lunchbox Fund. a charitable or8ani5Otion re815tered in the United States. The Lunchbox Fund provides nutrltious meals to Khool children in South Africa to support education and alleviate hunger. By ensuring children receive daily meals, the organisation helps improve attèndance. academlc performance. and overall well-belng.

The CH Foundatson IUKI IA Company Limlted by Guarantee) Charity Registration No.. 1156222 Company Registration No: 08702259 Trustees, Report (continuedj Achlevements and Performance Icontinuedj During the perlod. the Foundatbn granted $142,8571£118,0051 to The UC Berkeky Foundatlon I"UC8F°I. UC8F supports the Untvèrsity of Cal*ornia, Berkeley by raising and managing private funds to enhance the uniwerslty's mi55ion of teachin& research. and pubh'¢ 5ervieÈ.The grant is the flrst installment of a $1,000,O(M) pledge by the Foundation, The funds will be Used by UCBF's"Blological kiences Division" and contribute towards research whlch aim5 to Improve the climate and 8Èneral health of humans. During the pèriod. the Foundatlon also made two12023'. four) further 8rants to charitable donatlon5 totalllng £206,331 (year ended 28 February 2023.. £36,538). Subsequent Events and Fulure Plans The Foundation is antKipating a continued increase in donations kn the next financial year to allow it to increase its activities in the forthcomin8 years in order to meet the maSn objectives of the Foundation and to ensure that the appllcatlon of anv Income for the publlc benefrt 15 exclusively for charitable objects and purposes. There have been no signlficant events which requke further dtsclosure since the financial per￿d end and the date these financial #atements were authorlsed for155ue. Ind•pendent Audltors The auditors. Pricewatèrhousecoopers, have expressed their willingness to remain li office for a further year. On behalf of the Board Matthew Kln8 Trustee Date: 19 December 2024

The CH Foundation IUKI IA Company Limited by Guarantee) Charity Registration No-. 1156222 Company Registration No: 08702259 Statement of Trustees, Responslbllltles Trustees, re$ponslblllties In relation to the financO•l statements The Trustees (who are also directors of Thè CH Foundation (UK) Ithe "Ftsundation") for the purposes of company law} are fesponsible for preparin8 the Trustees, Annual Report and the financial statements In accordonce with applicable law and regulation. Company law requlres the Trustees to p￿pare financial statements for each financial period. Under that law the Trustees have prepared the financlol statements in accordance wlth United Kingdom Accounting Standards. comprlsxiB FRS 102 "The Financlal Reportlng Standard applicable in the UK and Republic of Ireland" and applicable law (United Kingdom Generally Accepted Accounting Practlcel. Under company law the Trustees must not approve the financial statements unless they are satisfied that they 8ive a true and fair vlew of the state of the affairs of the Foundation and of the Incoming resources and pplication of resources, Including the income and expenditure, of the Foundation for that period. In preparin8 these financial statements, the Trustees are required to.. • select sultable accovntlng policles and then apply them <0n515tentlyi • observe the methods and principles in the Accountin8 and Reportin8 by Charities.. Statement of Recommended Prac¢ice11 January 20191; • make ludgemenls and estimates that are reasonablè and prudent: • state whether appllcable UK Accountlng Standards, comprlslng FRS 102, have been followed, subject to any materlal departures disclosed and explained in the financial statements.. and prepare the financial statements on the going coneern basis unless it 15 inappropriate to presume that the Foundation will contlnue In business. The Tru5tee5 are responsible for keepin8 adequate atcountin8 records that are sufficient to show and explain the Foundatlon's transactions and disclose with reasonable accuracy at any time the financial position of the Foundation and enable them to ensure that the flnanclal statements comply with the Companles Act 2006. They are also responslble for safeguarding the assets of the Foundatlon and hence lor takln8 reasonable steps for the prevention and detectlon of fraud and other Irre8ularltles. The Trustees are ￿ponSIble for the malThtenan￿ and Inte8rity of Foundatlon's webslte. Le8lslatlon In the Unlted Kingdom 8overning the preparatlon and dlssemlnatlon of flnanclal staiemenfs may dlffer from leglslatlon In other Surlsdictlons. By order of the Board of Trustee5 Matthew Kln8 Ichalr) Trustee Date., 19 Oecember 2024

Independent auditors’ report to the members of The CH Foundation (UK)

Report on the audit of the financial statements

Opinion

In our opinion, The CH Foundation (UK)’s financial statements:

We have audited the financial statements, included within the Trustees' Report and Financial Statements, which comprise:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (“ISAs (UK)”) and applicable law. Our responsibilities under ISAs (UK) are further described in the Auditors’ responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Independence

We remained independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, which includes the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

Conclusions relating to going concern

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

However, because not all future events or conditions can be predicted, this conclusion is not a guarantee as to the company's ability to continue as a going concern.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Reporting on other information

The other information comprises all of the information in the Trustees' Report and Financial Statements, other than the financial statements and our auditors’ report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and, accordingly, we do not express an audit opinion or, except to the extent otherwise explicitly stated in this report, any form of assurance thereon.

10

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If we identify an apparent material inconsistency or material misstatement, we are required to perform procedures to conclude whether there is a material misstatement of the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report based on these responsibilities.

With respect to the Trustees’ Report, we also considered whether the disclosures required by the UK Companies Act 2006 have been included.

Based on our work undertaken in the course of the audit, the Companies Act 2006 requires us also to report certain opinions and matters as described below.

Trustees’ Report

In our opinion, based on the work undertaken in the course of the audit, the information given in the Trustees’ Report for the period ended 31 March 2024 is consistent with the financial statements and has been prepared in accordance with applicable legal requirements.

In light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we did not identify any material misstatements in the Trustees’ Report.

Responsibilities for the financial statements and the audit

Responsibilities of the trustees for the financial statements

As explained more fully in the Trustees’ Responsibilities Statement, the trustees are responsible for the preparation of the financial statements in accordance with the applicable framework and for being satisfied that they give a true and fair view. The trustees are also responsible for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors’ responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Our audit testing might include testing complete populations of certain transactions and balances, possibly using data auditing techniques. However, it typically involves selecting a limited number of items for testing, rather than testing complete populations. We will often seek to target particular items for testing based on their size or risk characteristics. In other cases, we will use audit sampling to enable us to draw a conclusion about the population from which the sample is selected.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Based on our understanding of the company and industry, we identified that the principal risks of non-compliance with laws and regulations related to health and safety legislation and licensing regulations, and we considered the extent to which non-compliance might have a material effect on the financial statements. We also considered those laws and regulations that have a direct impact on the financial statements such as the Companies Act 2006 and UK taxation legislation. We evaluated management’s incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls), and determined that the principal risks were related to the potential for fraudulent transactions to overstate reported revenue through manual journals. Audit procedures performed included:

11

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the FRC’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditors’ report.

Use of this report

This report, including the opinions, has been prepared for and only for the company’s members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

Other required reporting

Companies Act 2006 exception reporting

Under the Companies Act 2006 we are required to report to you if, in our opinion:

We have no exceptions to report arising from this responsibility.

Entitlement to exemptions

Under the Companies Act 2006 we are required to report to you if, in our opinion, the trustees were not entitled to: prepare financial statements in accordance with the small companies regime; take advantage of the small companies exemption in preparing the Trustees’ Report; and take advantage of the small companies exemption from preparing a strategic report. We have no exceptions to report arising from this responsibility.

Aisling Fitzgerald for and on behalf of PricewaterhouseCoopers Chartered Accountants and Statutory Auditors Dublin 19 December 2024

12

The CH Foundation IUKI IA Company ts'mited by Guarantee) Charity Re8lStration No.. 1156222 Company Re81Stratic￿ No: 08702259 Statement of Flnancial Actlvlties for the Perlod Ended 31 March 2024 Period Ended Year Ended 28 31 March 2024 FÈbruary 2023 Note Income Donation$ and legacles Investment intomè Total Intom• 152.145.861 193,780 152,339,641 78,306.794 208.495 78.515,289 EXp9nd5￿re Expendlture on charitable artlvitles Other expenditure Total •xpendlturo 4 1139,596,0911 1464.3461 1140,060,4371 169.726,8421 169,726,842) N¢1 In¢*)m• 12.279,204 8 788,447 Gain on investments ILossl18ain on forelgn •xchan8e io 3,739,783 1125.519) 1,385,643 208,562 N•t mg¥ement In funds 15,893,468 10,382,652 Recondllatlon of funds Total funds brou8ht forward 15 24,455,044 14.072,392 Total lund5 c•rrl•d forw•rd 40,348,512 24.455,044 The Statement of Flnancial Activities has been pr•pared on the ba515 that all actlvities are contlnuiw. There are no reco8nlsed gains and10sses other than those Included in the result5 above and iherelore no sÈparate statement of toial recognlsed 8ains and105ses has be•n presented. The accounting policies and the notes on pages 16 to 22 form part of the Flnanclal Stat•ments. 13

The CH Foundation IUKI IA Company Limited by Guarantee) Charity Registration No,. 1156222 Company Registration No: 08702259 Balance Sheet as at 31 March 2024 31 March 2024 28 February 2023 Note Flxed Asset5 Tangible assets Investments io 20.488,477 20,488,477 16,748,694 16,748,694 Current assets Debtors Cash èt bank and In hand Total current assets li 3,254,660 23,354,066 26,608,726 7,548,846 286,139 7,834,98S Llabllltles Creditors.. amounts fallin8 due within one year Net current JS5•ts 6.748,6911 12 ￿ 1128,6351 19.860,035 7.706,350 Total n•t ass•Is 40.348,512 24.455,044 The funds of the Found•tlon: Unrestrlcted Funds Tot•1 Found•tlon fund$ 15 40,348,512 40,348,512 24,455,044 24,455,044 The accountin8 policies and the notes on page5 16 to 22 form part of the Flnanclal Statements. The Financlal Statements were approved by the Trustees and authorlsed for Issue on 19 December 2024 and $18ned on thelr behalf by: Matthew Klnq Trustee 14

The CH Foundation IUKI IA Company Limited by Guarantee) Charity Re8iStration No.. 1156222 Company Registrètion No.. 08702259 Statement of Cash Flows for the Period Ended 31 March 2024 Period Ended Year Ended 28 31 March 2024 February 2023 Note Net cash generated by operating adivities 16 57,756,935 2,260,032 Cash Ilow from Investlni actlvltk5 Assets acqulred for donation Purchase of investmèrts Disposal of investments Net cash used In Investlng actl¥ltles 9 134.689.0081 io io 124,634,587) 14,780,7S2 19.853.835) 134,689,008) Net Increaselldecr•ase) In cash and cash equlvalents 23.067.927 17,593.8031 Cash and cash equivalents al the be8hnln8 of the perlodlyear 286,139 7,879,942 C05h and rash equlvalents •t the end of the perlodlye•r 23.354.066 286.139 Cash and ush equlvalents ¢onslsl$ of: Cash at bank and in hand 23,354.066 286.139 The Foundation has no net debt and accordingly no net debt note is presented. The accountln8 pollcles and the notes on pa8es 16 to 22 form part of the Financial Statements.

The CH Foundation IUKI IA Company Limited by Guaranteel Charity Registration No= 1156222 Company Registration No: 08702259 Notes to the Flnanclal Statements l General Inforrnatlon The CH Foundation IUKI (the 'Foundatlon") is a Charltable Company limited by 8uarantee, registered in England and Wales. The addre55 of Its reglstered office15 7 Clifford Street, London, WIS 2Fr. During the period, the Foundatlon changed Its accountlng reference datè from 28 February {29 February In a leap yearl to 31 March. The financlal statements are for the 13 month period to 31 March 2024, whilst the comparatives are for the 12 month period to 28 February 2023. Unless otherwise noted, references to "Period Ended 31 March 2024" in the flnanclal statements, including the headers, are for the 13 month perlod from l March 2023 to 31 March 2024. 2 Statement ol compllan¢¢ The f￿anCIal statements have been prepared In accordance with Charities SORP IFRS 1021 Accountlng and Reporting by Charlties: Statement of Recommended Practice applicablé to ¢harities preparing thelr accounts In accordance with the Flnanclal Reportin8 Standard applKable in the UK and Republic of Ireland IFRS 1021 (effective l January 20191, the Financlal Reporting Standard applicable In the UK and Republic of Ireland IFRS 1021 and the Companies Act 2006. Thè Foundation meets the definition of a public benefit entlty under FRS 102. Assets and liabilities are initlally reco8nlsed at historical Cost or transaction value unless otherwlse stated in the relevant a¢countin8 pollcy note. 3 A¢¢ountlni polkles The principal accounting pollcies applled in the preparation ol these flnanaal statements are set out below, These policies have been con515tently applied to all the perlods presented, unless otherwise stated, la} Le8al st•tu$ The Foundation bs a company Ilmlted by 8uèrantee and In the event of It being wound up each member is liable to ctsntribute a sum not exceedlng £10. There are no shares of any class, either authorlsed or allocated. (bl Golni concern The Foundation meèts its day-tO44•y working capital requlrements ihrou8h Its cash balances and investments. After reviewin8 the Foundation's forecasts and prolectlons. the Trustees have a reasonable expectatlon that the Foundation has adequate resources to continue in operational existence for the foregeeabk future. The Foundation therefore contlnues to adopt the going concern basis in preparing its financ*1 statements. Icl Incorne Income is included in the respectlve line Items of the Statement of Financial Actlvlties when the Foundatlon has entitlement to the Income, It Is probable that the economic benefits asslxlated wlth the transactlon wlll flow to the Foundation ¥nd the amount can be quantifièd with reasonable certainty, Id) Glfts In klnd and donated ser¥l¢es Gifts in kind and donated services are valued and Included. where materwl, in the financial ststements, The contribution of volunteers has been excluded from the Statement of Financial A¢tivitle5 a5 the volue of their contribution to the Foundation cannot be reasonably quantified in financial terms. Due to the Immaterial nature of donated Services and the dlfficulty In quantifying the financial impact of same In the current period, therÈ were no amounts included in respect of same. lel Expendlture Expenditure 15 accounted for on an accruals basis. Construttfve obligatlons1Sncluding grants payable) arè accounted for as liabilities where it is probable that there will be a transfer of economlc benefits and the amount of the obligation can be reliably estimated and communlcated to the reclplent. Costs of charitable activities ¢ompri5e all costs incurred in the pursuit of the charitable objects. These costs. where not wholly attrlbutable, are apporth)ned between the categoTies of charltable expenditure in addition to the direct C05tS. lfj Support and govemance costs Support COSts are those costs which do not relate dire¢tty to a single activity- Governance costs are those costs incurred in the compliance with constitutional and statutory requirements Including related professional fees. and are accounted for on an accruals basis. These costs are Included under the heading charitable aetivities in the Statement of Financlal Actfvities. 16

The CH Foundation IUKI IA Company Limited by Guarantee) Charity Registration No: 1156222 Company Registratlon No.. 087022S9 Notes to the Financial Statements (continued) 3 Attountln8 Polkles (CLintlnuedJ lfj Support and 8o¥eman¢e costs (contlnued) Support and governancè costs havè been apportionèd between charltable actlvltles on an expendlture basis. whereby the Costs are allocated proportionate to the nature of the grant funded artivity. Igl Forelgn ¢urreney translatlon Monetary assets and 4abilitie5 denorninat￿ in foreign currenciès are translatèd into pound sterllng at thè rates of exchange ruling at the Balance Sheet date, Tran50Ctions in foreign currencie5 are recorded at the rate ruling at the date of transaction. All differences are taken to the Statement of Flnanclal Actlvltles. Ih) Funds Unrestrirted Funds comprise those funds which the Trustees are free to Use In accordance wSth the charltable oblertlves of the Foundatlon. Restrlrted Funds comprise those funds that can onty be used for partlcular re5trlcied purposes Wlthln the oblectlve5 of the Foundatlon. RestrKted Fund5 arise when the funds are specified as such by the donorlsl OT when funds are raised for particular restricted purposes. Expendable Endowment Funds include all fund5 received which the Trustees are authori5ed to spend when and if they decide io s￿rtd thesè funds. The funds may be used to further the speclfic charitable purposes the Foundation was established to SUPPQrt. These costs can include both direct and support costs associated with activities undertaken by the restricted funds wlthin the FOUndat￿n. 111 Tanzlble flxed a55et5 Tangible fixed assets are recognlsed when it 6 probable that the expected future economlc beneflts assoclated wlth the asset will flow to the Foundation and the cost or falr value of the asset can be measured rellablv. {1) Investments Investment5 comprise non.controllin8 interests in investment funds whlch are measured at falr value. The falr value of the investments are detèrmined by the net asset value of each fund as at the reporting perlod end date. Changes In falr value are recognised In the Statement of Financial Acllvities, Cash and cash equlvalenls Cash and cash equlvalents Indudes cash In hand and bank overdrafts. Bank overdraft5, where applicable, are shown wlthin l)orrowing5 in current liabilities. 11) Flnanclal Instruments The Foundation has ch05en to adopt Section 11 of FRS 102 in respect of financial instruments. (l) Flnonclol ossets ond Investment5 Basic financial assets. includlng recelvèbles. and cash and cash equivalents. are initialty recognised at transaction price. unless the arrangement constitutes a financin8 transaction. where the transaction is measured at the present value of the future elpts dlscounted at a market rate of interest. Such assets are subsequently carried at amortised cost usin8 the effective interèst method. At the end of each reportlng perlod financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impalrment Ioss is the difference between the carrylng amount and the present value of the estimated cash flow5 discounted at the assevs original effertive interest rate. The impairment loss is recognised in the Statement of Financlal Activities. Other financial asset5, includin8 inve5tmer)ts. are initially measured at fair value. which is normally thè transactlon price. Such assets are subsequently carried at fair value and the changes in fair value are reco8ni5ed in profit or loss, except that investments in equity instruments that are not publdy traded and whose falr values cannot be MeaSu￿d reliably are measured at cost less impairment. 17

The CH Foundation IUKI IA Company Limited by Guarantee) Charity Re8iStrotion No- 1156222 Company Registratlon No: 08702259 Notes to the Flnanclal Statements (continued) 3 AcwuntlnB Pollrle5 fcontinuedj (11 Flnanclal In5trument5 (contlnued) (iij Finonciol liobilities Basic financial liabilities, including tradè and other payablès. are initially re¢ognisÈd at transaction prite. unlèss the arrangement constitutes a financing tran5actbon. where the debt instrument 15 measured at the present value of the future receipts discounted at a market rate of interest. Trade payables are obligatlons to pay for goods or 5eryices that have been acquired in the oidinary couise of business from suppliers. Trade payables are reco8nised initially at transactlon price and subsequently measured at amorti5ed cost using the effective interest method. {rnl Crltlcal accourtlng ludzements and estlmatlon uncertalnlv Estlmates and Sudgements are continually evaluated and are based on historical experience and other fadors, induding expectations of future events that are belleved to be reasonable under the clrcumstances. The preparatlon of flnanclal statements in conformity with FRS 102 requires the use of certain critical accountln8 estimates. It also requires management io exerclse Its judgement In the process ol applylng the Foundatlon's accounting policies. The falr value of the Investments In the investment funds are determlned by the proportionate interest of the net asset value of each Investment fund as at the reporting period end date. The Trustees place reliance on the accuracy of the net asset value of the investment funds, determined by the l)oards of the investment funds and. If appllcable. appolnted external valuers. The key accountln8 lud8ements and estlmates In determinin8 the net asset value ol the investment funds are the fair value measurements of the flnanclal Instruments held by the Investment funds. The valuation of unquoted investments is based on an independent valuation of the investments, based on the underlyin8 asset values In the accounts of the unquoted Investment entlty. There Is a level of estimatlon involved in these valuatlons, The Trustees review the individual valuations applied which includes subsequent performance of the invesiment and takes account of advlce provided by external investment advisors. 4 Expendlt¥re on ¢harltabl¢ a¢t6vltSes Grant funded Support & Period Ended Year Ended 28 actlvity governance 31 March 2024 February 2023 Humanitarian aid Advancement of educatlon and promotlon of health 4,716,170 134,845,809 139,561.979 1,153 4,717,323 32,959 134,878,768 34,112 139,596,091 11,759,982 57,966,860 69,726,842 Analysls of support and 8ov¢rnan¢e tost$ General Governance Period Ended Year Ended 28 support funrtion 31 March 2024 February 2023 Governance costs Office empenses 20,000 20,(KIO 14,112 34.112 15,763 9,849 25,612 14,112 14,112 20.000 S Other expenditure Period Ended Year Ended 28 31 March 2024 February 2023 Interest expense 464.346 464,346 The interest expense repre5ent5 Interest on gift aid repayable to HMRC. 18

The CH Foundation IUKI IA Company Limhted by Guarantee) Charity Re8lStratlon No.. 1156222 Company Registration No.. 08702259 Notes to the Flnanclal Statements (continued) 6 Staff rnsts The Foundation had no Èmployees durin8 the period (year ended 28 February 2023: nill- The Foundation considers its key management personnel to comprise of the Trustees. The Trustees were not paid, nor received any benefits. from the Foundatlon durlng thè period (year ended 28 February 2023.. £nill. The Trustee5 were not reimbursed expenses durlne the perlod Iyeaf ended 28 February 2023- £nlll. No Trustee received payment for profe55lonal or other services supplied to the Foundation lyear ended 28 February 2023.. £nill. 7 Taxailon The Foundatlon Is exempt from tax on incomè and gains falling withln sectlon 505 of the Taxes Act 1988 or section 252 of the Taxatlon of Chargeable Gains Act 1992 to the extent that these are applied to its chafltable objeds. 8 Net Inwm¢ Period Ended Year Ended 28 31 March 2024 February 2023 Net Income 15 Stated after char8ing.' Glft aid reduction Fees payable to the Foundation's auditors for the audit of the flnanclal statements 6,158.647 20,OCKJ 15.750 9 Assels acqulred for donatlon Durlng the period. the Foundation entered Into a real estate purchase agreement to a¢qulre a property in the USA for a purchase price, indusive of transactlon costs and taxes, of Y4,069,4371£34,689,0081. The Foundation a150 entered Into donatlon agreement with MANA Nutiitive Aid Product5 Incorporated I'MANA'I, a charitable or8ani5ation reglstefed in the USA. to grant the rights, title and interest In the property to MANA. The property was donated to MANA durin8 the period. The Foundation did not reco8nise the property as a tangible fixed asset on the basis there was no ewnomic beneflt to the Foundation from the property on an on-going ba51s. Period Ended Year Ended 28 31 March 2024 February 2023 Land and bulldlws Brought forward Acqui51tion5 Donations 34,689,(J)8 I34,689,(￿3) Carrled forward 10 Investmenls Period Ended Year Ended 28 31 March 2024 February 2023 Brought forward Additions D6p05als Galn on financlal assets at fair value Carried forward 16.748,694 5,509.216 24,634,587 114,780.7521 1.385,643 16.748,694 3,739,783 20.488.477 Investments represent sUbscript￿n5 in two {28 February 2023.. two) unlisted investment fund5 and a non-controlling interest in a limrted liability partnership incorporated in En8land and Wales (the 'LLP"I, The fair value of the investments are determined by the net asset value of the unlisted investment funds and the LLP as at thè reporting period end date. Changes in fair value are recognised in the Statement of Flnancial Activities. 19

The CH Foundation IUKI IA Company Llmited by Guarantee) Charity Re8iStration No: 1156222 Company Registration No.. 08702259 Notes to the Financlal Statements (continued) 10 In￿StmentS {continuedJ At the pÉriod end. the value of the investment In one of the unllsted Investment funds was £4,673.776 128 February 2023- £4,699.7191. The unlisted Investment fund provides debt financin8 to flnancial institution5 and water and sanitation enterprises providin8 water supply and sanitation microloans, product5, or servlces to famllies living In India, Indonesia, Cambodia. and the Philippines. The unllsted investment fund expects to reach 4.6 mlllion people with safe watèr or sanitation over its seven year Ilfe. At the period end, the value of the investment In the other unllsted Investment fund was £14,707,435 (28 February 2023: £10,879,305). At the period end, the value of the FoundatKJll'5 non-controllln8 interest in the LLP was £1.107,266 128 February 2023: £1,169,670). 11 Debtors 31 March 2024 28 February 2023 Loan receivable Other recelvables Accrued income Prepayment5 336,572 7,917 2,897,706 351.097 7.917 7.134,079 55,753 7,548,846 3,254,660 Accrued income represents gift ald on donatlons recelved durlng the perlodlyear. 12 Credltor$: amounts fJllln8 due wlthln one year 31 March 2024 28 February 2023 Amounts owed to related parties Trade payables Accruals Other payables 105,672 26 20.CA)O 6,622,993 6,748,691 57,285 55.600 15.750 128,635 The amounts owed to related parties are unsecured, interest free and repayable on demand, Other payables represents 81ft ald, Includlng Interest. repayable to HMRC. 13 Flnanclal Instwments 31 March 2024 28 February 2023 Frnanclal assets at falr value 20,488,477 16,748.694 Financlal 055et5 that are debt Instruments. measured at amortised cost.. Loans recelvèble Other receivables 336.572 7,917 344,489 351,097 7,917 359.014 Financlal liabilitie5 measured at amortised cost.. Trade payables 26 55,600

The CH Foundation IUKI IA Company Llmited by Guaranteel Charity Registration No.. 1156222 Company Registration No: 08702259 Notes to the Flnanclal Statements (continued) 14 Flnandal rfsk manaqement The Foundatlon's financlal ac￿vIt￿es may expose It to a variety of financial risks, broadly grouped as market risk. credit risk and liquidity risk. ma￿tt rlsk The Foundation's exposure to market risk 15 limited to currency exchanBe risk and price risk. The currency exchan8e risk arises from the investments held in currencies Other than the funrtional currency of the Foundation. The Foundation does not actively seek to hedge Its exposure to foreign exchange risk. The price risk arises on the investments due to their exposure to fluctuations In market prices lother than currency exchange riskl, whether those changes are caused by factors specific to the financial instrument or It5 issuers. or factors affecting all slmllar financial Instruments traded in the market. Credlt rlsk The Foundatlon's exposure io credit risk arises mainly through its tash balances and loan receivable. The Foundation wlll hold all tash wlth banks whom the Foundation ha5 5tron8. well-estoblished relationshlps and who typically have a minimum Moody'5 or S&P rating of Investment grade. The Foundatlon monltors the borrower's financial performance on a quarterly basls, At the reportin8 date, the maximum exposure to credit risk is represented by the carrying amount In the Balance Sheet. Llquldlty rlsk Llquidlty rlsk Is the rlsk that the Foundation wlll encounter difflcultles In rneetlng the obllÉations associated with its financial liabllities that are settled by delverln8 cash or another financial asset. The Foundation expects to meet it5 financlal obligations throu8h opÈratin8 cash flows. In the event that the operating cash flows would not cover all the flnancial obli8ation5 the Foundation has cash reserves and credit focllities available. 15 Unrestrlcted fvnds l March 2023 IntominB Resources Resources Expended 31 March 2024 Unrestricted 24,455,044 155,953,905 140,060,437) 24,455,044 ISS,9S3.905 1140,060,4371 40.348.S12 40.348.S12 16 Noles to ihe Slatement ol Cash Flow$ Period Ended Year Ended 28 31 March 2024 February 2023 Net income for the flnanclal perlodlyear 15,893,468 10,382,652 Adlu5tments for.. Donation of assets {non.cash movementl Gain on financial asset5 at falr value Decrea5e/lincreasel In debtors Increase in creditors Net cash generated by operating activities 34,689,008 (3.739,7831 4,294,186 6.620,056 57.756,935 11,385,643) 16,820,091> 83,114 2,260,032 17 Contln8enl Ilabllltles and finand¥l comrnltments The Foundatlon had commitments at the per￿d end of £9.434.487128 February 2023.. £24,631,403). The Foundatlon has Èntered into grant agreements with charitable organisations and made grants avallable as drawdown facilities over the 8rant terms. The commltment5 at the period end represent the remainder of the total committed 8rants that the charitable organisations have not drawdown. The Foundation will fund the commitments through existing cash balances and future donations Tecewed. The Foundation had no contin8ent liabilities at 31 March 2024128 February 2023: £nill. 21

The CH Foundation IUKI IA Company Limited by Guaranteel Charity Registration No-. 1156222 Company Reglstratlon No: 08702259 Notes to the Flnanclal Statements (continuedj 18 R¢laied party trans•rtlon$ During the period, the Foundation received donatlons wtthout conditions of £1SS,085.979 Iyear ended 28 February 2023.. £71,124,699) from related partles. Durin8 the period, the Foundation received profit distrlbution advances of £105.672 (year ended 28 February 2023.. £57,285) from the LLP. The amount is reco8nised as a liability until the LLP allocates the profits. The LLP Is related through C. Hohn beng a trustee of the LLP'S controlling partv. 19 Controllln8 party The controllin8 party are the Trustees actin8 in the General Meeting. 2Q Subsequent events There have been no significant events whlth requlre further disclosure since the financlal period end and the date thesè flnanclal statements were authorised for issue.